AAVXF
Price
$7.28
Change
+$1.47 (+25.30%)
Updated
Jun 11 closing price
Capitalization
513.87M
ACHV
Price
$2.18
Change
-$0.08 (-3.54%)
Updated
Jul 3 closing price
Capitalization
108.31M
34 days until earnings call
Interact to see
Advertisement

AAVXF vs ACHV

Header iconAAVXF vs ACHV Comparison
Open Charts AAVXF vs ACHVBanner chart's image
Abivax SA
Price$7.28
Change+$1.47 (+25.30%)
Volume$300
Capitalization513.87M
Achieve Life Sciences
Price$2.18
Change-$0.08 (-3.54%)
Volume$817.66K
Capitalization108.31M
AAVXF vs ACHV Comparison Chart in %
Loading...
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. ACHV commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and ACHV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (AAVXF: $7.28 vs. ACHV: $2.18)
Brand notoriety: AAVXF and ACHV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 177% vs. ACHV: 122%
Market capitalization -- AAVXF: $513.87M vs. ACHV: $108.31M
AAVXF [@Biotechnology] is valued at $513.87M. ACHV’s [@Biotechnology] market capitalization is $108.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileACHV’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • ACHV’s FA Score: 0 green, 5 red.
According to our system of comparison, AAVXF is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 3 TA indicator(s) are bullish while ACHV’s TA Score has 4 bullish TA indicator(s).

  • AAVXF’s TA Score: 3 bullish, 2 bearish.
  • ACHV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AAVXF is a better buy in the short-term than ACHV.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while ACHV (@Biotechnology) price change was -37.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($514M) has a higher market cap than ACHV($108M). AAVXF YTD gains are higher at: -34.118 vs. ACHV (-38.068). ACHV has higher annual earnings (EBITDA): -44.37M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. ACHV (23.2M). ACHV has less debt than AAVXF: ACHV (9.96M) vs AAVXF (92.6M). AAVXF (0) and ACHV (0) have equivalent revenues.
AAVXFACHVAAVXF / ACHV
Capitalization514M108M476%
EBITDA-170.04M-44.37M383%
Gain YTD-34.118-38.06890%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M23.2M448%
Total Debt92.6M9.96M930%
FUNDAMENTALS RATINGS
AAVXF vs ACHV: Fundamental Ratings
AAVXF
ACHV
OUTLOOK RATING
1..100
4352
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
5993
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AAVXF's Valuation (67) in the null industry is in the same range as ACHV (70) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's Profit vs Risk Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as ACHV (99) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's Price Growth Rating (59) in the null industry is somewhat better than the same rating for ACHV (93) in the Biotechnology industry. This means that AAVXF’s stock grew somewhat faster than ACHV’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFACHV
RSI
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
24%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TISCX28.68N/A
N/A
Nuveen Large Cap Responsible Eq R6
FHETX16.59N/A
N/A
Fidelity Advisor Real Estate M
VSQRX17.55N/A
N/A
Invesco MSCI World SRI Index R
BMSTX14.81N/A
N/A
MFS Blended Research Mid Cap Eq R3
ANVRX10.22N/A
N/A
American Century Non-US Intrs Val R

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ABOS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.54%
ABOS - ACHV
41%
Loosely correlated
+2.65%
GLSI - ACHV
38%
Loosely correlated
+1.52%
EYPT - ACHV
37%
Loosely correlated
+0.62%
ARCT - ACHV
37%
Loosely correlated
+1.17%
NAUT - ACHV
36%
Loosely correlated
+4.73%
More